Gencor Industries Inc: Form 10-Q for the period ended Mar 31, 2020
Filed with the SEC on May 4, 2020 and accepted by EDGAR at May 4, 2020, 09:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2020-01-01 to 2020-03-31 | $26.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Revenue | 6 months2019-10-01 to 2020-03-31 | $44.0m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 3 months2020-01-01 to 2020-03-31 | $18.7m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2019-10-01 to 2020-03-31 | $32.4m | us-gaap:CostOfRevenue |
| Research and development | 3 months2020-01-01 to 2020-03-31 | $689.0k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2019-10-01 to 2020-03-31 | $1.5m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2020-01-01 to 2020-03-31 | $2.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2019-10-01 to 2020-03-31 | $4.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2020-01-01 to 2020-03-31 | $4.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-10-01 to 2020-03-31 | $5.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2020-01-01 to 2020-03-31 | −$164.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-10-01 to 2020-03-31 | $458.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2020-01-01 to 2020-03-31 | −$655.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-10-01 to 2020-03-31 | $1.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2020-01-01 to 2020-03-31 | −$0.04 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-10-01 to 2020-03-31 | $0.12 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2020-01-01 to 2020-03-31 | −$0.04 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-10-01 to 2020-03-31 | $0.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2020-01-01 to 2020-03-31 | 14,586,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-10-01 to 2020-03-31 | 14,714,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-10-01 to 2020-03-31 | $9.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2019-10-01 to 2020-03-31 | $718.0k | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2020-03-31 | $18.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-03-31 | $161.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-03-31 | $169.7m | us-gaap:Assets |
| Current liabilities | At period end2020-03-31 | $11.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-03-31 | $12.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-03-31 | $157.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-20-131864. Last ingested by Listed: Oct 24, 2026, 14:53 ET. Listed shows no prices and gives no investment advice.